Loading organizations...
Phrontline Biopharma has raised $73.7M across 2 funding rounds.
Phrontline Biopharma has raised $73.7M in total across 2 funding rounds.
Phrontline Biopharma has raised $73.7M in total across 2 funding rounds.
Phrontline Biopharma's investors include 王及, Decheng Capital, Med-Fine Capital, Samsung, Sino Biopharmaceutical.
Phrontline Biopharma has raised $73.7M across 2 funding rounds. Most recently, it raised $60.0M Pre-Series A in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 25, 2025 | $60M Seed Plus | 王及 | Decheng Capital, MED Fine Capital, Samsung, Sino Biopharmaceutical | Announced |
| Jun 27, 2024 | $13.7M Seed Plus | Decheng Capital | — | Announced |
